L. Pusztai

发表

Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response.

C. Criscitiello, G. Curigliano, G. Viale, 2023, European journal of cancer.

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency.

G. Hortobagyi, P. Sharma, S. Stecklein, 2023, JCO precision oncology.

Immunological differences between primary and metastatic breast cancer

L. Pusztai, D. Rimm, V. Bossuyt, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.

H. Rugo, P. Beitsch, E. Cobain, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.

G. Hortobagyi, K. Albain, C. Ambrosone, 2024, Cancer chemotherapy and pharmacology.

Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.

G. Hortobagyi, K. Albain, C. Ambrosone, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Associations amongst genes, molecules, cells, and organs in breast cancer metastasis.

D. Chitale, S. Nathanson, L. Pusztai, 2023, Clinical & experimental metastasis.

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer

V. Karantza, H. Iwata, H. Mukai, 2023, JAMA network open.

Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer.

G. Bianchini, F. Miglietta, L. Licata, 2024, Cancer treatment reviews.

CECR2 Drives Breast Cancer Metastasis by Suppressing Macrophage Inflammatory Responses 1 2

D. Rimm, Asako Aoshima, Hongyin Sun, 2020 .

Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets

L. Pusztai, C. Hatzis, B. Aktas, 2014, Breast Cancer Research and Treatment.

Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer

Rajarsi R. Gupta, N. Rajpoot, S. Loi, 2024, The Journal of pathology.

Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer.

S. Loi, J. Balko, G. Sonke, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.